Grid radiation may boost sarcoma treatment before surgery

NCT ID NCT06073067

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This pilot study tests a special radiation technique called GRID therapy given before standard radiation and surgery for people with soft tissue sarcoma in their arms or legs. The goal is to see if GRID can safely increase the radiation dose to the tumor without causing more wound problems after surgery. Twenty adults with high-risk sarcoma will receive one GRID treatment, then standard radiation, then surgery. Researchers will track wound complications and how much of the tumor is killed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GRID radiation therapy
What this could lead to
If successful, this could improve tumor shrinkage before surgery without increasing wound complications, potentially leading to better outcomes for sarcoma patients.
What could go wrong
This is a very small pilot study (20 people) with no control group, so results may not be generalizable. The main risk is wound complications after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTREMITY SOFT TISSUE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.